公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B | Chiang L.-T.; MING YAO ; BOR-SHENG KO ; CHIEN-HUNG CHEN | Infection | 4 | 5 | |
2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 179 | 173 | |
2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 174 | 160 | |
2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 5 | 6 | |
2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 195 | 184 | |
2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 30 | 25 | |
2024 | Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations | FENG-MING TIEN ; CHI-YUAN YAO ; Tsai, Xavier Cheng-Hong; Lo, Min-Yen; Chen, Chien-Yuan; WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Peng, Yen-Ling; Tseng, Mei-Hsuan; Wu, Yu-Sin; Liu, Ming-Chih; LIANG-IN LIN ; MING-KAI CHUANG ; BOR-SHENG KO ; MING YAO ; Tang, Jih-Luh; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 0 | | |
2020 | Economic burden of cancers in Taiwan: A direct and indirect cost estimate for 2007-2017 | Huang S.-Y.; Chen H.-M.; Liao K.-H.; BOR-SHENG KO ; FEI-YUAN HSIAO | BMJ Open | 16 | 16 | |
2017 | An efficient transfection method for differentiation and cell proliferation of mouse embryonic stem cells | Liou J.-Y.; BOR-SHENG KO ; Chang T.-C. | Methods in Molecular Biology | 2 | 0 | |
2010 | An efficient transfection method for mouse embryonic stem cells | Liou, Jun-Yang; BOR-SHENG KO ; Chang, Tzu-Ching | Methods in molecular biology (Clifton, N.J.) | 9 | 0 | |
2009 | An efficient transfection method for mouse embryonic stem cells | BOR-SHENG KO ; Chang T.C.; Shyue S.K.; YAO-CHANG CHEN ; Liou J.Y. | Gene Therapy | 20 | 17 | |
2021 | Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO | International Journal of Clinical Practice | 9 | 6 | |
2022 | The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan | HUAI-HSUAN HUANG ; Chen C.-M.; Wang C.-Y.; Hsu W.W.-Y.; Chen H.-M.; BOR-SHENG KO ; FEI-YUAN HSIAO | PLoS ONE | 4 | 4 | |
2018 | Erratum: Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma (Oncotarget (2015) 6 (38967-38982) DOI: 10.18632/oncotarget.5734) | Liu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Lu Y.-J.; Liang S.-M.; Liu C.-C.; Chen S.-C.; Wang J.; Shyue S.-K.; Liou J.-Y. | Oncotarget | 0 | 0 | |
2020 | Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia | Lu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Chen L.; CHIH-CHENG WU ; Chin C.-H.; Kuo C.-C.; Yet S.-F.; Liou J.-Y. | Aging | 12 | 12 | |
2013 | Expression of partitioning defective 3 (Par-3) for predicting extrahepatic metastasis and survival with hepatocellular carcinoma | Jan Y.-J.; BOR-SHENG KO ; Liu T.-A.; YAO-MING WU ; Liang S.-M.; Chen S.-C.; Wang J.; Liou J.-Y. | International Journal of Molecular Sciences | 23 | 20 | |
1999 | Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - The occurrence of retinoic acid syndrome is a risk factor | BOR-SHENG KO ; JIH-LUH TANG ; YAO-CHANG CHEN ; MING YAO ; Wang C.-H.; MING-CHING SHEN ; HWEI-FANG TIEN | Leukemia | 77 | 61 | |
2020 | Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis | Liao K.-H.; BOR-SHENG KO ; Chen L.-K.; FEI-YUAN HSIAO | Clinical and Translational Science | 2 | 2 | |
2010 | Focal Adhesion Kinase as a Therapeutic Target of Bortezomib | BOR-SHENG KO ; Chang T.-C.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 6 | 6 | |